Patents by Inventor Alex Veithen

Alex Veithen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058240
    Abstract: A self-tanning composition, such as a sunless tanning composition, a moisturizing composition, or a haircare composition, includes a self-tanning substance. The composition can result in increasing the amount of melanin in melanocytes, increasing melanin synthesis, improving melanin transport, and/or improving the distribution of melanin in suprabasal layers. The composition can be used in methods for darkening skin and/or for sunless tanning.
    Type: Application
    Filed: June 25, 2021
    Publication date: February 22, 2024
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL
  • Patent number: 11867685
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: January 9, 2024
    Assignee: CHEMCOM S.A.
    Inventors: Sandra Huysseune, Alex Veithen, Yannick Quesnel
  • Publication number: 20220378675
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 1, 2022
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Patent number: 11382848
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: July 12, 2022
    Assignees: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Publication number: 20220125983
    Abstract: A malodor counteracting composition has nefopam, or a polymorph, a hydrate or a solvate thereof. The malodor counteracting composition is useful as an attenuator or suppressor for attenuating or suppressing malodors, such as earthy malodor, musty malodor, and/or moldy malodor caused by malodor causing agents, such as geosmin and 2-methylisoborneol.
    Type: Application
    Filed: May 6, 2019
    Publication date: April 28, 2022
    Inventors: Alex VEITHEN, Pierre CHATELAIN, Yannick QUESNEL
  • Publication number: 20210164967
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Application
    Filed: December 5, 2018
    Publication date: June 3, 2021
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL
  • Publication number: 20190374451
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: January 30, 2018
    Publication date: December 12, 2019
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Patent number: 8993526
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: March 31, 2015
    Assignee: ChemCom S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • Patent number: 8637259
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: January 28, 2014
    Assignee: ChemCom S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • Publication number: 20130336910
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Application
    Filed: June 12, 2013
    Publication date: December 19, 2013
    Applicant: CHEMCOM S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • Patent number: 8008023
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: August 30, 2011
    Assignee: Chemcom S.A.
    Inventors: Frédéric Sallman, Alex Veithen, Magali Philippeau
  • Publication number: 20090264526
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Application
    Filed: May 12, 2008
    Publication date: October 22, 2009
    Applicant: Chemcom S. A.
    Inventors: Frederic Sallman, Alex Veithen, Magali Philippeau
  • Publication number: 20090226403
    Abstract: The present invention is related to an olfactory or pheromone G-protein coupled receptor having an amino acid sequence which presents 95% sequence identity with the sequence SEQ ID NO. 1.
    Type: Application
    Filed: April 26, 2007
    Publication date: September 10, 2009
    Inventor: Alex Veithen
  • Publication number: 20030221205
    Abstract: The present invention is related to an olfactory or pheromone G-protein coupled receptor having an amino acid sequence which presents 95% sequence identity with the sequence SEQ ID NO. 1.
    Type: Application
    Filed: March 13, 2003
    Publication date: November 27, 2003
    Inventor: Alex Veithen